T. Ueda

发表

Platinum accumulation in the kidney and liver following chemotherapy with cisplatin in humans.

S. Naito, J. Kumazawa, J. Uozumi, 1993, International urology and nephrology.

Phase II trial of carboplatin in patients with advanced germ-cell testicular tumors and transitional cell carcinomas of the urinary tract

T. Matsuda, T. Miki, H. Akaza, 2004, Cancer Chemotherapy and Pharmacology.

Prophylactic intravesical chemotherapy with adriamycin plus verapamil for primary superficial bladder cancer: preliminary results

S. Naito, J. Kumazawa, K. Sagiyama, 2004, Cancer Chemotherapy and Pharmacology.

Ultrastructural Alterations and DNA Synthesis of Renal Cell Nuclei following Cisplatin or Carboplatin Injection in Rats

J. Kumazawa, J. Uozumi, T. Ueda, 1992, The Journal of pharmacy and pharmacology.

Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.

J. Kumazawa, J. Uozumi, T. Ueda, 1992, Pharmacology & toxicology.

Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.

J. Uozumi, T. Ueda, T. Yasumasu, 1991, The Journal of toxicological sciences.

Intravesical therapy with adriamycin plus verapamil in patients with superficial bladder cancer: a pilot study.

J. Kumazawa, S. Naito, K. Sagiyama, 1992, Urologia internationalis.

The effect of methylprednisolone on cisplatin-induced nephrotoxicity in rat renal cortical slices

J. Kumazawa, J. Uozumi, T. Ueda, 1995, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro

J. Kumazawa, J. Uozumi, T. Ueda, 1996, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Methylprednisolone reduces the nephrotoxicity caused by cisplatin.

J. Uozumi, T. Ueda, Y. Koikawa, 1992, Journal of pharmacobio-dynamics.

Serum immunosuppresive acidic protein in renal cell carcinoma

T. Ueda, 2004, Urological Research.

Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma.

S. Naito, J. Uozumi, T. Ueda, 1993, British journal of urology.

Intravesical treatment of bladder cancer with recombinant human interferon-β

H. Ueda, S. Kagawa, T. Niijima, 1989, Cancer Immunology, Immunotherapy.

Clinical significance of urinary enzymes and beta 2-microglobulin following ESWL.

S. Naito, J. Kumazawa, J. Uozumi, 1994, International urology and nephrology.

Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.

J. Kumazawa, S. Naito, K. Sagiyama, 1991, Urology.

Adjuvant chemotherapy with early intravesical instillation of Adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer

S. Naito, J. Kumazawa, K. Sagiyama, 2004, Cancer Chemotherapy and Pharmacology.

Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results

J. Kumazawa, K. Sagiyama, A. Iguchi, 2004, Cancer Chemotherapy and Pharmacology.

Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese urological cancer research group for Adriamycin

Y. Ohashi, H. Akaza, T. Machida, 2004, Cancer Chemotherapy and Pharmacology.

[Recurrence following surgery for primary renal pelvic and ureter cancer--clinicopathologic analysis of distant metastasis].

J. Kumazawa, S. Naito, M. Nakamura, 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Percutaneous endopyelotomy for ureteropelvic junction obstruction in a horseshoe kidney.

S. Naito, J. Kumazawa, J. Uozumi, 1996, Scandinavian journal of urology and nephrology.

Clinical study of asymptomatic microscopic haematuria

J. Kumazawa, J. Uozumi, T. Ueda, 2007, International Urology and Nephrology.

Comparison of clinical and pathological characteristics in incidentally detected and suspected renal carcinoma.

S. Naito, J. Uozumi, T. Ueda, 1991, British journal of urology.

Treatment of advanced hormone-refractory prostate carcinoma with a combination of etoposide, pirarubicin and cisplatin

S. Naito, J. Kumazawa, K. Sagiyama, 2004, Cancer Chemotherapy and Pharmacology.

Clinical significance of urinary enzymes and β2-microglobulin following ESWL

S. Naito, J. Kumazawa, J. Uozumi, 1994, International Urology and Nephrology.

Early and quantitative detection of cisplatin-induced nephrotoxicity by measurement of plasma PSP (phenolsulfonphthalein) half-life in rats.

J. Kumazawa, J. Uozumi, T. Ueda, 1993, Nihon Jinzo Gakkai shi.

Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer

H. Akaza, T. Machida, T. Niijima, 1987, Cancer Chemotherapy and Pharmacology.

Recurrence of bladder tumors following surgery for transitional cell carcinoma of the upper urinary tract.

J. Kumazawa, S. Naito, M. Nakamura, 1991, European urology.

Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. Kyushu University Urological and Radiological Oncology Group.

K. Hasuo, J. Kumazawa, S. Naito, 1995, The Journal of urology.

Calcium blockers enhance cisplatin-induced nephrotoxicity in rats

J. Kumazawa, J. Uozumi, T. Ueda, 1992, International Urology and Nephrology.

Prophylactic chemotherapy with intravesical instillation of Adriamycin and oral administration of 5-fluorouracil after surgery for superficial bladder cancer

Y. Ohashi, H. Akaza, S. Kagawa, 2004, Cancer Chemotherapy and Pharmacology.

The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin

Y. Ohashi, H. Akaza, T. Machida, 2004, Cancer Chemotherapy and Pharmacology.

Phase III trial of The Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder

H. Akaza, T. Machida, T. Niijima, 2004, Cancer Chemotherapy and Pharmacology.

Sigmoidocystoplasty after total cystectomy for bladder cancer: A follow-up study

J. Kumazawa, T. Ueda, Hiromi Kawano, 1986, The Japanese journal of surgery.

Evaluation of systemic chemotherapy with methotrexate, vinblastine, Adriamycin, and cisplatin for advanced bladder cancer

Y. Ohashi, H. Akaza, T. Machida, 2004, Cancer Chemotherapy and Pharmacology.